Sean Wharton, MD, PharmD, discusses the SYNCHRONIZE-2 data presented at EASD 2026, highlighting the GLP-1/glucagon dual agonist’s potential.
Sean Wharton, MD, PharmD
Advertisement
Sean Wharton, MD, PharmD, is the medical director of Wharton Medical Center.
Articles by Sean Wharton, MD, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
US Alcohol Use Falls, but Not for Adults Aged 50 to 64, With Brian Lee, MD
2
Nail Detachment 4 Times More Common With GLP-1 Use
3
EASD 2026: EloraTZP Bests Tirzepatide on Weight Loss, A1C in Type 2 Diabetes
4
FDA Approves Mavacamten for Pediatric Patients With Obstructive HCM
5